Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344578 · ClinicalTrials.gov registry record
Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 120
- Enrollment target
NCT00344578: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT00344578 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00344578 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas
Interventions
- DEVICE Restor IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-07 |
What the finished NCT00344578 record still lists
NCT00344578 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Restor IOL is the first listed.
NCT00344578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00344578 about?
NCT00344578 is a clinical study titled "Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review". To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas
What is the current status of trial NCT00344578?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2006-03. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00344578?
The interventions under investigation include: Restor IOL (DEVICE).
Who is sponsoring clinical trial NCT00344578?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia